Neffy nasal spray included in Express Scripts formularies enhances access for patients with Type 1 allergic reactions.Quiver AI SummaryARS Pharmaceuticals, Inc. announced that neffy® (epinephrine nasal...
Justin Chakma, the Chief Business Officer of $SPRY ($SPRY), sold 27,272 shares of the company on 12-13-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 16.7%...
Justin Chakma, the Chief Business Officer of $SPRY ($SPRY), sold 50,000 shares of the company on 12-10-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 26.8%...
ARS Pharmaceuticals' neffy® nasal spray receives approval filings in China, Japan, and Australia for treating severe allergic reactions.Quiver AI SummaryARS Pharmaceuticals, Inc. announced that its licensing...
Sarina Tanimoto, the CHIEF MEDICAL OFFICER of $SPRY ($SPRY), sold 50,000 shares of the company on 12-10-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.9%...
Justin Chakma, the Chief Business Officer of $SPRY ($SPRY), sold 45,000 shares of the company on 12-03-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 24.8%...
Laura Shawver, a director at $SPRY ($SPRY), sold 14,772 shares of the company on 12-04-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.6% of their shares....